Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Medicinal chemistry

New lead for pain treatment

The synthesis of conolidine, a scarce, naturally occurring compound, has enabled the first studies of its pharmacological properties to be carried out. Excitingly, conolidine is a painkiller that seems to have an unusual mechanism of action.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Get just this article for as long as you need it


Prices may be subject to local taxes which are calculated during checkout

Figure 1: Inspiration for the synthesis of conolidine.


  1. Tarselli, M. A. et al. Nature Chem. 3, 449–453 (2011).

    Article  ADS  CAS  Google Scholar 

  2. Kam, T.-S., Pang, H.-S., Choo, Y.-M. & Komiyama, K. Chem. Biodiver. 1, 646–656 (2004).

    Article  CAS  Google Scholar 

  3. Potier, P. & Janot, M. M. C.R. Acad. Sci. 276C, 1727 (1973).

    Google Scholar 

  4. Scott, A. I., Yeh, C.-L. & Greenslade, D. J. Chem. Soc. Chem. Commun. 947–948 (1978).

  5. Rice, K. C. in The Chemistry and Biology of Isoquinoline Alkaloids (eds Phillipson, J. D., Roberts, M. F. & Zenk, M. H.) 191–203 (Springer, 1985).

    Book  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Sarah E. Reisman.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Reisman, S. New lead for pain treatment. Nature 473, 458–459 (2011).

Download citation

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research